203118-32-5

Basic information

• Product Name: (E)-3-(3,4-bis((tert-butyldimethylsilyl)oxy)phenyl)acrylic acid
• Synonyms: (E)-3-(3,4-bis((tert-butyldimethylsilyl)oxy)phenyl)acrylic acid
• CAS NO: 203118-32-5
• Molecular Weight: 408.685
• Mol File: 203118-32-5.mol
• Article Data: 22

Chemical Properties

• CAS DataBase Reference: (E)-3-(3,4-bis((tert-butyldimethylsilyl)oxy)phenyl)acrylic acid(CAS DataBase Reference)
• NIST Chemistry Reference: (E)-3-(3,4-bis((tert-butyldimethylsilyl)oxy)phenyl)acrylic acid(203118-32-5)
• EPA Substance Registry System: (E)-3-(3,4-bis((tert-butyldimethylsilyl)oxy)phenyl)acrylic acid(203118-32-5)

Safety Data

• Hazardous Substances Data: 203118-32-5(Hazardous Substances Data)

Upstream product

• 368836-74-2 3,4-bis-(t-butyldimethylsilyloxy)caffeoyl aldehyde 
• 288-32-4 1H-imidazole 
• 331-39-5 caffeic acid 
• 18162-48-6 tert-butyldimethylsilyl chloride 
• 69739-34-0 t-butyldimethylsiyl triflate 
• 331-39-5 caffeic acid 
• 139-85-5 3,4-dihydroxybenzaldehyde 
• 141-82-2 malonic acid 
• 99815-16-4 3,4-bis(tert-butyldimethylsilanyloxy)benzaldehyde 
• 368836-73-1 (E)-methyl 3-(3,4-bis((tert-butyldimethylsilyl)oxy)phenyl)acrylate 
• 244293-59-2 3-[3,4-di(t-butyldimethylsiloxy)phenyl]prop-2-en-1-ol 
• 3843-74-1 Methyl caffeate 
• 203118-31-4 di-O-t-butyldimethylsilylcaffeic acid t-butyldimethylsilyl ester 

Downstream Products

• 210890-98-5 3,4-di(t-butyldimethylsilyloxy)-cinnamoyl chloride 
• 1256291-08-3 bis(diphenylmethyl) 2-(3,4-di(tert-butyldimethylsilyloxy)cinnamoyl)-3-(N-(p-fluorobenzyl)-2-pyrroloyl)-L-tartrate 
• 116511-71-8 3,4-bis(O-tert-butyldimethylsilyl)-3,4-dihydroxyhydrocinnamic acid 
• 71939-67-8 (R)-1-methyl-2-[(S)-6-oxo-3,6-dihydro-2H-pyran-2-yl]ethyl 3-(3,4-dihydroxyphenyl)propanoate 
• 107585-47-7 tubastrine 

Relevant articles and documents

Synthesis of tunichrome Sp-1

The first total synthesis of the ascidian blood pigment tunichrome Sp-1 is reported, with the modified pentapeptide prepared in a convergent manner using a combination of solid-phase peptide synthesis, Hunsdiecker decarboxylative iodination and Buchwald a

Synthesis of the proposed structure of sibiriaester B and evaluation of its immunomodulatory properties

Herein, we report a concise synthesis of the proposed structure of sibiriaester B, a novel antioxidant phenyl caffeate derivative isolated from the leaves of Armeniaca sibirica. Proposed sibiriaester B was obtained via simple esterification between the known TBS-protected caffeic acid and the commercially available methyl 4-hydroxybenzoate, and subsequent deprotection. However, the NMR spectral data of the synthesized sibiriaester B were not consistent with those in previous reports. The structure of the synthesized sibiriaester B was confirmed using combined 2D-NMR analysis, including COSY, HSQC, and HMBC. The synthesized sibiriaester B was observed to exhibit more potent immunomodulatory activity in murine epidermal T cells than p-hydroxyphenyl caffeate, an immunomodulatory natural caffeate derivative, as treatment with sibiriaester B significantly reduced the production of interleukin 13 by murine epidermal T cells at lower concentrations than p-hydroxyphenyl caffeate.

Glucosamine derivative

To provide a novel substance useful as a functional substance having a biomass-derived structure and a composite function.SOLUTION: A glucosamine derivative is represented by formula (I) (Ris H, a protective group of a hydroxy group or an organic group other than the hydroxy group protective group; R-Rare different from Rand independently represent H or a hydroxy group protective group; n is an integer of 2-5; and Rindependently represent H or a phenolic hydroxyl group protective group).SELECTED DRAWING: None